SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-11-052647
Filing Date
2011-11-09
Accepted
2011-11-09 16:03:58
Documents
5
Period of Report
2011-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PDL BIOPHARMA, INC. 8K 11-9-2011 form8k.htm 8-K 32995
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 276127
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 39460
4 EXHIBIT 99.3 ex99_3.htm EX-99.3 293064
5 GRAPHIC graphic.jpg GRAPHIC 4637
  Complete submission text file 0001140361-11-052647.txt   649436
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 111191713
SIC: 2836 Biological Products, (No Diagnostic Substances)